Major Expansion of In-House Pharmaceutical Production Capacity

Aiming to expand in-house tablet production capacity to more than 20 billion tablets annually, and ultimately to approximately 25 billion tablets, by utilizing acquired assets and personnel and investing in equipment at multiple plants.